NASDAQ$CDLX

Cardlytics Inc · Q2 2021 earnings

Q2 2021 earnings · · Investor relations

Briefing

Cardlytics' Q2 2021 financial results were announced, revealing increased revenue and billings, but also a net loss.

Cardlytics announced its Q2 2021 financial results, with revenue increasing by 109% year-over-year to $58.9 million and billings increasing by 116% to $85.3 million. However, the company reported a net loss attributable to common stockholders of $(47.3) million, or $(1.43) per diluted share.

  • Revenue increased by 109% year-over-year to $58.9 million.
  • Billings increased by 116% year-over-year to $85.3 million.
  • Gross profit increased by 193% year-over-year to $23.2 million.
  • Net loss attributable to common stockholders was $(47.3) million, or $(1.43) per diluted share.

Headline financials

Total Revenue

$58.9M

Previous: $28.2M+108.5%
EPS (adj)

-$0.39

Previous: -$0.38-2.6%
Net Income

-$47.3M

Previous: -$19.8M-139.4%
Operating Income

-$42.7M

Previous: -$19.7M-116.6%
Gross Profit

$23.2M

Previous: $28.2M-17.8%
Cash & Equivalents

$251M

Previous: $98.4M+154.8%
Total Assets

$1.23B

Previous: $183M+573.6%

Revenue & EPS history

Cardlytics · Revenue · Quarterly

$58.9M

Q2 2021+108.5%vs Q2 2020
Beat estimate in 7 of 16 quarters(44%)
ActualEstimate

Forward guidance

Cardlytics anticipates billings, revenue, and adjusted contribution to be in the following ranges for Q3 2021: Billings $85.0 - $95.0 million, Revenue $57.0 - $66.0 million, Adjusted contribution $27.0 - $32.0 million.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2021

Historical avgQ2 2021

-6.1%

Avg return

Earnings day

-6.2%

Avg return

5 days after

+14.5%

Avg return

30 days after

47%

16 / 34 earnings

Positive

+68.6%

Q4 2023

Best reaction

-59.6%

Q2 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-2.0%-15.0%+654.7%
Q4 2025-9.9%-21.8%+25.6%
Q3 2025-28.5%-16.5%-37.5%
Q1 2025-13.0%-2.8%-17.1%
Q4 2024+4.5%+18.7%-25.3%
Q3 2024-13.2%-3.0%-15.8%
Q2 2024-59.6%-51.9%-53.1%
Q1 2024-39.8%-40.8%-43.4%
Q4 2023+68.6%+64.0%+57.8%
Q3 2023-55.7%-47.6%-40.1%
Q2 2023+15.7%+21.2%+42.8%
Q1 2023-26.0%-29.4%-29.9%
Q4 2022-10.8%-9.4%-37.7%
Q3 2022-52.2%-51.2%-52.9%
Q2 2022+18.3%+10.6%-7.6%
Q1 2022+10.2%-8.5%-24.2%
Q4 2021+5.7%-7.1%-5.2%
Q3 2021+6.7%+8.3%-20.4%
Q2 2021-32.5%-29.2%-22.3%
Q1 2021-20.6%-24.8%-24.2%
Q4 2020+1.2%-3.3%-17.2%
Q3 2020+2.9%+22.7%+56.5%
Q2 2020-9.1%-8.9%+0.8%
Q1 2020+13.0%+8.9%+50.9%
Q4 2019-36.4%-43.7%-64.3%
Q3 2019+43.6%+42.9%+44.4%
Q2 2019+20.0%+24.1%+39.8%
Q1 2019+20.9%+14.8%+47.1%
Q4 2018-5.6%-11.7%-7.2%
Q3 2018-24.9%-19.9%-29.3%
Q2 2018+0.3%+3.0%+27.3%
Q2 2017+0.3%+3.0%+27.3%
Q1 2018-1.0%-7.4%+6.5%
Q4 2017+1.0%+0.5%-13.6%
Q3 2017
Q1 2017
Q4 2016
Q3 2016
Q2 2016
Q1 2016

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro